<DOC>
	<DOCNO>NCT00897026</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor plan best treatment . PURPOSE : This research study look tissue sample woman underwent chemotherapy lymph node-positive stage II stage IIIA breast cancer .</brief_summary>
	<brief_title>Studying Tissue Samples From Women Who Underwent Chemotherapy Lymph Node-Positive Stage II Stage IIIA Breast Cancer Clinical Trial CLB-9741 CLB-9344</brief_title>
	<detailed_description>OBJECTIVES : Primary - To identify biomarkers use individually tailor use adjuvant dose-dense therapy woman stage II IIIA breast cancer . Secondary - To identify group patient poor prognosis despite adjuvant chemotherapy prospectively target new approach adjuvant treatment . OUTLINE : This multicenter study . Tissue sample collect patient . Tissue sample analyze immunohistochemistry ( Ki67 , CK5/6 , EGFR , ER ) fluorescence situ hybridization ( FISH ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nodepositive breast cancer Stage IIIIIA disease Underwent adjuvant chemotherapy trial CLB9741 CLB9344 Hormone receptor status specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>